VC-Backed Crescendo Biologics Poaches Genzyme Pro
Matthew Roe will join Crescendo Biologics as its chief business officer, the company announced. The healthcare veteran comes from Genzyme Corp., where he most recently served as senior director of business development and licensing. The company has raised £4.5 million in seed funding from life sciences investors, Sofinnova Partners, Avlar BioVentures and the Rainbow Seed Fund.
22 June 2011•2 mins read
